not tagged
not tagged
['lymphoma']
yesterday, we shared preclinical and clinical data on our ptefb/cdk9 inhibitor vip152 in lymphoma at #eha22. read more: 
A clinical-stage company focused on leveraging its extensive development and #oncology expertise to advance new therapies for the treatment of #cancer.